News
HIMS
25.33
+4.89%
1.18
Noteworthy Friday Option Activity: HIMS, AMBA, VZ
NASDAQ · 1d ago
Hims & Hers New Growth Category Is a Huge Surprise
The Motley Fool · 1d ago
The FDA Can't Decide Whether Zepbound Is in Shortage. It's Good News for Hims & Hers Stock.
Barron‘s · 1d ago
Truist Financial Sticks to Their Hold Rating for Hims & Hers Health (HIMS)
TipRanks · 1d ago
HIMS Stock Surges after Court Case with Eli Lilly Gets Put on Hold
NASDAQ · 1d ago
Hims & Hers Health Expands Board with New Appointment
TipRanks · 1d ago
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or Within Seven Days Of FDA's New Decision
Benzinga · 1d ago
Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed
Seeking Alpha · 1d ago
Hold Rating on Hims & Hers Health Amidst Regulatory Uncertainty and Market Risks
TipRanks · 1d ago
FDA tirzepatide status report ‘moderately positive’ for Hims & Hers, says Citi
TipRanks · 2d ago
Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s
TipRanks · 2d ago
Hims & Hers announces daily meal replacement bars and shakes
TipRanks · 2d ago
January 2025 Options Now Available For Hims & Hers Health (HIMS)
NASDAQ · 2d ago
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
Barchart · 2d ago
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
The Motley Fool · 2d ago
Will Amazon Bury Hims Stock or Should You Buy the Dip?
NASDAQ · 3d ago
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead
Seeking Alpha · 3d ago
HIMS Factor-Based Stock Analysis
NASDAQ · 3d ago
Hims & Hers Health Price Target Maintained With a $28.00/Share by TD Cowen
Dow Jones · 3d ago
TD Cowen Reiterates Buy on Hims & Hers Health, Maintains $28 Price Target
Benzinga · 3d ago
More
Webull provides a variety of real-time HIMS stock news. You can receive the latest news about Hims & Hers Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About HIMS
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.